Skip to search formSkip to main contentSkip to account menu

FAP regimen

Known as: Fluorouracil-Adriamycin-Platinol Regimen 
A regimen containing fluorouracil, doxorubicin and cisplatin used for the treatment of advanced-stage gastric cancer.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
O presente estudo visou caracterizar e discutir a producao cientifica a respeito de FAP, mais especificamente estender o estudo… 
2014
2014
FAP-IL2v is a novel monomeric FAP-targeted immunocytokine where a single, engineered IL-2 variant (IL-2v) with abolished IL… 
2013
2013
IL-2 therapy can lead to durable responses in cancer patients, but is associated with significant toxicity. None of the described… 
2013
2013
Introduction: IL-2 therapy can lead to durable responses in a modest proportion of cancer patients, but the treatment is… 
2013
2013
IL-2 therapy can result in durable responses in a proportion of cancer patients, but the treatment is associated with significant… 
2012
2012
In enterprise scenarios, multi-femtocell deployments can be carried out to improve indoor services performance. In this… 
Highly Cited
2009
Highly Cited
2009
A new class of ionic liquids (ILs) containing the tris(pentafluoroethyl)trifluorophosphate (FAP) anion are paired with… 
2004
2004
胃癌の肝転移再発は予後不良であり, 標準的治療は確立されていない。TS -1 が無効で他臓器転移を認めない胃癌肝転移に対して, 5-FU , adriamycin (ADM ), cisplatin (CDDP )を用いた肝動注化学療法(FAP…